(Q37575639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

hepatocellular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Stephen L Chan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Anthony T C Chan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

889-899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

5 February 2020

cites work

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Novel advancements in the management of hepatocellular carcinoma in 2008.

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: is current therapy really altering outcome?

21 January 2018

1 reference

Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases

21 January 2018

1 reference

Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker

21 January 2018

1 reference

Microvessel density of malignant and benign hepatic lesions and MRI evaluation

21 January 2018

1 reference

Molecular imaging of hepatocellular carcinoma

21 January 2018

1 reference

Serum alpha-feto-protein and primary cancer of the liver in man.

21 January 2018

1 reference

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma

21 January 2018

1 reference

Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy

21 January 2018

1 reference

The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line

21 January 2018

1 reference

The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells

21 January 2018

1 reference

Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells

21 January 2018

1 reference

The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.

21 January 2018

1 reference

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

21 January 2018

1 reference

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis

21 January 2018

1 reference

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population

21 January 2018

1 reference

Prognostic prediction in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Staging systems in hepatocellular carcinoma

21 January 2018

1 reference

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

21 January 2018

1 reference

The global burden of hepatitis C

21 January 2018

1 reference

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

21 January 2018

1 reference

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation

21 January 2018

1 reference

Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma

21 January 2018

1 reference

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment

21 January 2018

1 reference

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

21 January 2018

1 reference

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

21 January 2018

1 reference

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

21 January 2018

1 reference

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

21 January 2018

1 reference

Natural history of untreated nonsurgical hepatocellular carcinoma

21 January 2018

1 reference

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

21 January 2018

1 reference

Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation

21 January 2018

1 reference

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

21 January 2018

1 reference

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival

21 January 2018

1 reference

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

21 January 2018

1 reference

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

21 January 2018

1 reference

Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels

21 January 2018

1 reference

Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein1

21 January 2018

1 reference

Prognostic features and survival of hepatocellular carcinoma in Italy

21 January 2018

1 reference

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.09.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19663737%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference